IGC Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGC Pharma and other ETFs, options, and stocks.About IGC
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development.
IGC Key Statistics
Stock Snapshot
IGC Pharma(IGC) stock is priced at $0.35, giving the company a market capitalization of 31.93M. It carries a P/E multiple of -4.47.
On 2025-12-13, IGC Pharma(IGC) stock traded between a low of $0.34 and a high of $0.37. Shares are currently priced at $0.35, which is +3.9% above the low and -5.9% below the high.
The IGC Pharma(IGC)'s current trading volume is 1.42M, compared to an average daily volume of 657.6K.
During the past year, IGC Pharma(IGC) stock moved between $0.25 at its lowest and $0.50 at its peak.
During the past year, IGC Pharma(IGC) stock moved between $0.25 at its lowest and $0.50 at its peak.
IGC News
IGC Pharma (IGC) has reached a key enrollment milestone of 65% for its ongoing Phase 2 CALMA clinical trial evaluating IGC-AD1 for the treatment of agitation in...